CSL Limited

CSLLYOTCHealthcare● Active

$17.12

+$0.00(+0.00%)

Market Cap$66.3B

P/E Ratio—

52W High$44.855

52W Low$16.29

Avg Volume548K

Open$17.15

Beta0.09

Free Cash Flow Financials Revenue

CSL Limited (CSLLY) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

CSLLY · free cash flow · updated Jun 9, 2026

Core FCF metrics

CSLLY · FCF · TTM · margin & CAGR

Free cash flow was $2.54B for FY2025 (fiscal year ending 2025-06-30), up 68.9% year-over-year The FCF margin was 16.5%. Five-year CAGR stands at +14.7%.

FY2025 Free Cash Flow$2.54B▲ +68.9% YoY

Trailing 12M (TTM)$5.37Btrailing 4 quarters sum

FCF Margin16.5%$2.54B ÷ revenue

3-Year CAGR+22.6%FY2022 → FY2025

5-Year CAGR+14.7%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 9, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

CSLLY · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$3.56B(1.02B)$2.54B▲ +68.9%16.5%

FY2024$2.76B(1.26B)$1.51B▲ +65.7%10.2%

FY2023$2.60B(1.69B)$909.0M▼ 34.2%6.9%

FY2022$2.63B(1.25B)$1.38B▼ 43.1%13.2%

FY2021$3.62B(1.20B)$2.43B▲ +89.3%23.6%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

CSLLY · P/FCF · FCF yield · FCF per share

CSL Limited (CSLLY) trades at a FCF yield of 9.47% and a price-to-free-cash-flow ratio of 12.3x. FCF per share stands at $1.39, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

9.47%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$1.39

TTM FCF ÷ Shares Outstanding

Price / FCF

x12.3

Share Price ÷ FCF per Share

EV / FCF (TTM)

x14.2

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-06-30

Cash flow statement summary

CSLLY · cash flow statement · operating / investing / financing

For FY2025, CSL Limited generated $3.56B in operating cash flow and spent 1.02B in capital expenditures, yielding $2.54B in free cash flow.

Operating Activities

+$3.56B

Cash from core business operations

2025-06-30

Investing Activities

−$850.0M

CapEx, acquisitions & investments

2025-06-30

Financing Activities

−$2.24B

Buybacks, dividends & debt

2025-06-30

FCF FormulaOperating CF ($3.56B) − |CapEx| (1.02B) = FCF ($2.54B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

CSLLY vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

CSL LimitedYOU

CSLLY

$2.54B+68.9%16.5%

13%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

CSL Limited (CSLLY) reported free cash flow of $2.54B for FY2025 (fiscal year ending 2025-06-30), up 68.9% year-over-year. The FCF margin was 16.5%.

Based on available data, CSL Limited has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $2.54B in FY2025. The 5-year CAGR stands at +14.7%.

CSL Limited's FCF yield is 9.47% and price-to-FCF ratio is 12.3x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

CSLLY free cash flow · 8 questions

CSL Limited free cash flow was $2.54B for FY2025, up 68.9% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $5.37B.

CSLLY free cash flowCSLLY FCFCSLLY FCF 2025CSLLY free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · CSL Limited · CSL Limited SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026